Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perillyl Alcohol in Metastatic Breast Cancer
NCT00003219Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- May 1998
- Primary completion
- May 1998
- Modality
- Nucleic Acid-Directed Small Molecules, Inhalation Devices, Covalent Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NEO100-02 in breast cancer, sponsored by University of Wisconsin–Madison. Started May 1998; status: completed.
02
Drugs
NEO100-02
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00003219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003219.